NJ-FREYR-SOLUTIONS
13.8.2024 07:50:33 CEST | Business Wire | Press release
Freyr, a premier global Regulatory solutions and services provider, proudly announces its distinguished placement as a Leader in the esteemed Everest Group Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® Assessment 2024. Freyr has emerged as the leader from this comprehensive evaluation of over twenty (20) global service providers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731962821/en/
Everest Group Life Sciences and Medical Affairs Operations PEAK Matrix® Assessment 2024 (Graphic: Business Wire)
The PEAK Matrix® offers an impartial, data-driven evaluation of service and technology providers, categorizing them as Leaders, Major Contenders, or Aspirants based on their overall capabilities and market impact.
“In the rapidly evolving regulatory landscape, enterprises face a myriad of challenges, such as navigating complex compliance frameworks, ever-changing regulations, and diverse geographical needs. Consequently, enterprises are increasingly reliant on external service providers with specialized knowledge and technological expertise to manage these complexities," says Lloyd Fernandes, Practice Director at Everest Group. He added, "Freyr's extensive market presence and robust affiliate network, bolstered by its localized expertise, make it adept at navigating diverse regulatory environments. Furthermore, its comprehensive portfolio of technological solutions built on the AI first Freya Fusion platform, along with its dedicated centers of excellence, enable it to effectively address clients' digitization and efficiency demands. These strengths have contributed to its Leader positioning in Everest Group's Regulatory and Medical Affairs Operations PEAK Matrix Assessment 2024."
Suren Dheenadayaalan, CEO of Freyr Solutions, expressed his delight, stating, "Securing the Leader position in the Everest Group Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® Assessment is a significant milestone for Freyr. This recognition reaffirms our commitment throughout the Regulatory value chain in the Life Sciences sector. We take pride in being recognized as a reliable global Regulatory partner and remain committed to fostering innovation while surpassing compliance standards in the intricate Regulatory landscape."
Rajiv Rangan, Co-founder of Freyr Solutions, added, "This acknowledgment from the prestigious Everest Group underscores our continued dedication to Regulatory services & solution excellence spanning over decade+ years. On behalf of the founding team of Freyr, I extend our sincere and heartfelt gratitude to our global colleagues and customers for their continued and invaluable support, without which this accomplishment would not have been possible."
About Freyr
Freyr Solutions provides global Regulatory solutions, with 2100+ experts supporting 1550+ customers in 120+ countries.
"Discover how Freyr leads the way in regulatory excellence—visit our website for more details. Freyr Solutions"
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240731962821/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Data to Be Highlighted in Four Rapid Oral Presentations at the European Society for Medical Oncology (ESMO) Congress 2026 Support Efforts to Improve Outcomes in Difficult-to-Treat Cancers17.7.2026 19:10:00 CEST | Press release
Rapid oral presentations will highlight new Phase 1 data across Incyte’s solid tumor portfolioBoth INCB161734, an investigational, potent, selective and orally bioavailable KRAS G12D inhibitor, and INCA338901, a TGFβR2×PD-1 bispecific antibody, are being evaluated in ongoing Phase 3 programs as first-line treatments for patients with advanced pancreatic ductal adenocarcinoma (PDAC) and microsatellite stable (MSS) colorectal cancer, respectively Incyte (Nasdaq:INCY) today announced that it will highlight data from several programs in its oncology portfolio in six presentations at the European Society of Medical Oncology (ESMO) Congress 2026, being held October 23 - 27, 2026, in Madrid. “The data at ESMO will further illustrate Incyte’s commitment to advancing innovation for patients with cancer,” said Pablo J. Cagnoni, M.D., President, Incyte and Global Head of Research and Development. "Among the presentations are important updates from our KRAS G12D inhibitor in advanced pancreatic ca
STL Expands Its Optical Connectivity Portfolio in the US with the CONCAT Solution17.7.2026 14:24:00 CEST | Press release
STL Optical Connectivity NA, LLC, (STLOC), a U.S. subsidiary of STL (Sterlite Technologies Ltd.) [NSE: STLTECH], a leading connectivity solutions provider for AI-ready digital infrastructure, today announced that it launched its new advanced FTTH solution, CONCAT, after successfully completing field trials on the networks of one of the largest telecom service providers in the United States. Following successful field validation, CONCAT is now available to digital infrastructure providers seeking faster fiber rollouts with reduced deployment complexity and labor. It enables up to 71% in labor cost savings by eliminating most field splicing through factory-assembled, pre-connectorized fiber segments that deliver plug-and-play installation. CONCAT simplifies fiber deployment by shifting critical fiber preparation and termination into a controlled manufacturing environment ensuring consistent quality, faster installation, and lower operational risk in the field. CONCAT solution is ideal fo
Aqemia and Sanofi Expand Their Research Collaboration17.7.2026 12:30:00 CEST | Press release
A new target nomination and a milestone payment mark the next step of the multi-year partnership first announced in December 2023 Aqemia, the drug invention company combining generative AI and quantum-inspired physics to invent small molecule drugs, today announced the expansion of its multi-year research collaboration with the global pharmaceutical company, Sanofi. The expansion is marked by the nomination of a new therapeutic target and an additional payment. The collaboration, first announced in December 2023, makes Aqemia eligible to receive up to a total of $140 million in upfront and milestone payments across programs. It spans the drug discovery journey from the identification of the very first hits to the selection of a development candidate. Aqemia leverages Qemi, its proprietary physics-based generative AI platform, to design novel molecules addressing Sanofi’s targets of choice, working in close collaboration with Sanofi scientific teams. Sanofi leads wet lab research, devel
China's ~$900B Live-Commerce Market Now Approaches US E-Commerce Scale17.7.2026 12:30:00 CEST | Press release
The consumer habits reshaping global retail were built in the East — and most Western shoppers haven't yet adopted them. NIQ report shows that brands still treating live, social, and quick commerce as "emerging" risk being left behind. The center of gravity in global retail has shifted East. The formats now driving the fastest growth in global retail (live shopping, social commerce, and delivery in minutes) were pioneered and scaled in Asia, and most Western consumers have yet to adopt them. According to NIQ (NYSE: NIQ), a leading consumer intelligence company, in its global report The Commerce Revolution: Where East Meets West, the gap between East and West is still vast. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260717253489/en/ China´s USD 900bn live shopping boom now approaches the scale of the US E-commerce The scale is already substantial. China's live-commerce market alone was worth roughly $900 billion in 2025,
Ant International’s Alipay+ Connects Argentina's National QR Payment Scheme via PVS,Enabling for Cross-Border Digital Payment Nationwide at Millions of Merchants17.7.2026 12:17:00 CEST | Press release
Alipay+, a global digital payment gateway under Ant International, today announced that it will enable global travellers to make QR code payments at millions of merchants across Argentina through integration with the country's national QR payment scheme Transferencias 3.0, in partnership with PVS, a fintech company specialized in developing customized payment solutions in Latin America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260717276406/en/ By connecting to Argentina's national QR payment scheme, Alipay+ now enables global travellers in the country to make convenient QR code payments at merchants nationwide. This service helps to enhance global travellers' travel experiences in Argentina, allowing them to pay seamlessly at restaurants, malls and tourist attractions. Using an Alipay+ partner payment app, they can now scan the national QR code displayed at all merchants to make cross-border payments across Argentina,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom